OB/GYN Clinical Alert – January 1, 2021
January 1, 2021
View Issues
-
Body Mass Index and Safety of Postpartum Tubal Ligation
In a single-institution, retrospective review of 3,670 postpartum tubal ligations performed after vaginal delivery, there was no association between increasing body mass index and surgical morbidity.
-
Is Universal Rescreening of Pregnant Women for Hepatitis C Cost-Effective?
In this cost-effectiveness analysis study, the authors assessed the cost effectiveness of offering hepatitis C virus (HCV) antenatal rescreening to U.S. women who previously were screened HCV negative in a prior pregnancy.
-
A New Nonhormonal Vaginal Gel Contraceptive
In this single-arm, open-label, Phase III study of a novel vaginal pH regulator gel among 1,384 sexually active women aged 18 to 35 years, the seven-cycle cumulative pregnancy rate was 13.7% (95% confidence interval, 10.0% to 17.5%).
-
Pap Smear Management: An Update on Recent Recommendations
Despite its current prevalence in the care of patients, the Pap smear has been used for less than 100 years. A major advancement in the field of screening came in the late 1970s and early 1980s with the identification that the human papilloma virus (HPV). Since the year 2000, there have been multiple progressive cycles of updates to both screening and management guidelines as the result of our rapidly evolving understanding of HPV.